{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:43:00Z","timestamp":1792730580006,"version":"4.5.0"},"reference-count":13,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,4,1]]},"abstract":"<jats:p>Hepcidin is a liver-made peptide proposed to be a central regulator of intestinal iron absorption and iron recycling by macrophages. In animal models, hepcidin is induced by inflammation and iron loading, but its regulation in humans has not been studied. We report that urinary excretion of hepcidin was greatly increased in patients with iron overload, infections, or inflammatory diseases. Hepcidin excretion correlated well with serum ferritin levels, which are regulated by similar pathologic stimuli. In vitro iron loading of primary human hepatocytes, however, unexpectedly down-regulated hepcidin mRNA, suggesting that in vivo regulation of hepcidin expression by iron stores involves complex indirect effects. Hepcidin mRNA was dramatically induced by interleukin-6 (IL-6) in vitro, but not by IL-1 or tumor necrosis factor \u03b1 (TNF-\u03b1), demonstrating that human hepcidin is a type II acute-phase reactant. The linkage of hepcidin induction to inflammation in humans supports its proposed role as a key mediator of anemia of inflammation.<\/jats:p>","DOI":"10.1182\/blood-2002-10-3235","type":"journal-article","created":{"date-parts":[[2003,3,17]],"date-time":"2003-03-17T15:22:55Z","timestamp":1047914575000},"page":"2461-2463","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1092,"title":["Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein"],"prefix":"10.1182","volume":"101","author":[{"given":"Elizabeta","family":"Nemeth","sequence":"first","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika V.","family":"Valore","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Territo","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Schiller","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lichtenstein","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ganz","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine and Pathology, David Geffen School of Medicine, and the West Los Angeles Veterans Administration Hospital, University of California, Los Angeles (UCLA), Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822094049900_B1","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver.","volume":"276","author":"Park","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111822094049900_B2","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822094049900_B3"},{"key":"2019111822094049900_B4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett."},{"key":"2019111822094049900_B5","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.","volume":"98","author":"Nicolas","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822094049900_B6","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.072632499","article-title":"Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.","volume":"99","author":"Nicolas","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822094049900_B7","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.","volume":"276","author":"Pigeon","year":"2001","journal-title":"J Biol Chem."},{"key":"2019111822094049900_B8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.","volume":"110","author":"Nicolas","year":"2002","journal-title":"J Clin Invest."},{"key":"2019111822094049900_B9","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1046\/j.1432-1033.2002.02881.x","article-title":"Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge.","volume":"269","author":"Shike","year":"2002","journal-title":"Eur J Biochem."},{"key":"2019111822094049900_B10","doi-asserted-by":"crossref","first-page":"37597","DOI":"10.1074\/jbc.M205305200","article-title":"The solution structure of human hepcidin, a peptide-hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.","volume":"277","author":"Hunter","year":"2002","journal-title":"J Biol Chem."},{"key":"2019111822094049900_B11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med."},{"key":"2019111822094049900_B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U","article-title":"Cytokines and the hepatic acute phase response.","volume":"181","author":"Moshage","year":"1997","journal-title":"J Pathol."},{"key":"2019111822094049900_B13","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein.","volume":"99","author":"Torti","year":"2002","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2461\/1267053\/h80703002461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/7\/2461\/1267053\/h80703002461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:09:48Z","timestamp":1574114988000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/7\/2461\/106644\/Hepcidin-a-putative-mediator-of-anemia-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-10-3235","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,1]]}}}